Publication | Open Access
Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial
113
Citations
18
References
2017
Year
The BOOST-2 trial does not support the use of nucleated BMCs in patients with STEMI and moderately reduced LVEF treated according to current standards of early PCI and drug therapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1